Glenda Fleming

1.2k total citations
21 papers, 698 citations indexed

About

Glenda Fleming is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Family Practice. According to data from OpenAlex, Glenda Fleming has authored 21 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Geriatrics and Gerontology, 6 papers in Economics and Econometrics and 5 papers in Family Practice. Recurrent topics in Glenda Fleming's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Medication Adherence and Compliance (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Glenda Fleming is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Medication Adherence and Compliance (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Glenda Fleming collaborates with scholars based in United Kingdom, Jordan and Indonesia. Glenda Fleming's co-authors include James C. McElnay, Carmel Hughes, Michael Scott, Claire Scullin, Christine M. Clark, Mohanad Odeh, Robert Horne, Janie Sheridan, Ian Bates and John Strang and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Clinical Pharmacology and Drug Safety.

In The Last Decade

Glenda Fleming

20 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenda Fleming United Kingdom 9 362 315 124 113 97 21 698
Khalid A. J. Al Khaja Bahrain 17 358 1.0× 312 1.0× 135 1.1× 153 1.4× 229 2.4× 59 1.0k
Mahmoud E. Elrggal Saudi Arabia 17 252 0.7× 198 0.6× 102 0.8× 122 1.1× 127 1.3× 61 879
Sewunet Admasu Belachew Ethiopia 18 191 0.5× 209 0.7× 154 1.2× 128 1.1× 77 0.8× 43 906
Mohamed Azmi Hassali Malaysia 19 263 0.7× 323 1.0× 178 1.4× 212 1.9× 60 0.6× 55 1.0k
Kumud Kumar Kafle Nepal 9 222 0.6× 221 0.7× 121 1.0× 172 1.5× 127 1.3× 16 680
Laurie L. Briceland United States 18 385 1.1× 220 0.7× 171 1.4× 151 1.3× 146 1.5× 54 1.0k
Linda Tahaineh Jordan 12 304 0.8× 136 0.4× 70 0.6× 95 0.8× 128 1.3× 33 569
Eman Abahussain Kuwait 15 319 0.9× 187 0.6× 60 0.5× 93 0.8× 181 1.9× 26 781
Tracey Thornley United Kingdom 16 229 0.6× 130 0.4× 192 1.5× 200 1.8× 67 0.7× 41 657
António Teixeira Rodrigues Portugal 14 198 0.5× 541 1.7× 174 1.4× 399 3.5× 78 0.8× 43 1.0k

Countries citing papers authored by Glenda Fleming

Since Specialization
Citations

This map shows the geographic impact of Glenda Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenda Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenda Fleming more than expected).

Fields of papers citing papers by Glenda Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenda Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenda Fleming. The network helps show where Glenda Fleming may publish in the future.

Co-authorship network of co-authors of Glenda Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Glenda Fleming. A scholar is included among the top collaborators of Glenda Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenda Fleming. Glenda Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scott, Michael, et al.. (2024). The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability. International Journal of Clinical Pharmacy. 46(5). 1001–1009. 2 indexed citations
2.
O’Neill, Katherine, Cairine Gormley, Martin Kelly, et al.. (2024). Service development project to pilot a digital technology innovation for video direct observation of therapy in adult patients with asthma. BMJ Open Quality. 13(3). e002626–e002626. 1 indexed citations
3.
Harper, Roy, Michael Scott, Glenda Fleming, et al.. (2022). Adherence to metformin in adults with type 2 diabetes: a combined method approach. Journal of Pharmaceutical Policy and Practice. 15(1). 61–61. 4 indexed citations
4.
O’Neill, Katherine, et al.. (2022). C-reactive protein point of care testing in community pharmacy: Observational study of a Northern Ireland pilot. Pharmacy Practice. 20(4). 1–10. 4 indexed citations
5.
Barnett, Nina, et al.. (2021). Approaching difficult situations: how to have challenging conversations. Pharmaceutical journal/˜The œpharmaceutical journal.
7.
Scullin, Claire, Sonja Grigoleit, Constandinos X. Mavromoustakis, et al.. (2021). Shaping the Future of Digitally Enabled Health and Care. SHILAP Revista de lepidopterología. 9(1). 17–17. 8 indexed citations
8.
Al‐Azzam, Sayer, Steven Williams, Wendy Wilson, et al.. (2021). General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial. Journal of Pharmaceutical Policy and Practice. 14(1). 4–4. 19 indexed citations
9.
Gormley, Cairine, et al.. (2021). Medicines Optimisation for Respiratory Patients: The Establishment of a New Consultant Respiratory Pharmacist Role in Northern Ireland. SHILAP Revista de lepidopterología. 9(4). 177–177. 5 indexed citations
10.
Odeh, Mohanad, et al.. (2020). A novel approach to medicines optimisation post-discharge from hospital: pharmacist-led medicines optimisation clinic. International Journal of Clinical Pharmacy. 42(4). 1036–1049. 12 indexed citations
11.
Scott, Michael, et al.. (2019). Analysis of activities undertaken by ward-based clinical pharmacy technicians during patient hospital journey. European Journal of Hospital Pharmacy. 28(6). 313–319. 3 indexed citations
13.
Odeh, Mohanad, Claire Scullin, Glenda Fleming, et al.. (2019). Ensuring continuity of patient care across the healthcare interface: Telephone follow‐up post‐hospitalization. British Journal of Clinical Pharmacology. 85(3). 616–625. 37 indexed citations
14.
Fleming, Glenda, et al.. (2017). The Impact of a Pharmacist Independent Prescriber on the Discharge Processes at the Weekend in an Acute Hospital. International Journal of Integrated Care. 17(5). 548–548. 1 indexed citations
15.
Scott, Michael, et al.. (2015). Integrated medicines management to medicines optimisation in Northern Ireland (2000–2014): a review. European Journal of Hospital Pharmacy. 22(4). 222–228. 18 indexed citations
16.
Fleming, Glenda, James C. McElnay, & Carmel Hughes. (2004). Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study. Pharmacy World & Science. 26(5). 282–288. 35 indexed citations
17.
Fleming, Glenda, James C. McElnay, & Carmel Hughes. (2003). The Separation of Codeine from Nonprescription Combination Analgesic Products. Substance Use & Misuse. 38(9). 1217–1226. 7 indexed citations
18.
Bates, Ian, et al.. (2001). An occupational survey of hospital pharmacists in the south of England. UCL Discovery (University College London). 12 indexed citations
19.
Hughes, Carmel, James C. McElnay, & Glenda Fleming. (2001). Benefits and Risks of Self Medication. Drug Safety. 24(14). 1027–1037. 475 indexed citations
20.
Fleming, Glenda, James C. McElnay, Carmel Hughes, Janie Sheridan, & John Strang. (2001). The role of the community pharmacist in drug abuse: a comparison of service provision between Northern Ireland and England/Wales.. Pharmacy World & Science. 23(1). 13–16. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026